Human Molecular Genetics Advance Access originally published online on September 2, 2004
Human Molecular Genetics 2004 13(21):2699-2708; doi:10.1093/hmg/ddh280
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 13, No. 21 © Oxford University Press 2004; all rights reserved
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia
1Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashicho, Kodaira, Tokyo 187-8502, Japan, 2Neuronics R.G. Special Division for Human Life Technology, National Institute of Advanced Industrial Science and Technology, 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan, 3Department of Psychiatry, Fujita Health University School of Medicine, 1-98 Kutsukakechotagakugakubo, Toyoake, Aichi 470-1192, Japan, 4Department of Psychiatry, Nagoya University Graduate School of Medicine, 65 Tsurumai, Chuoku, Nagoya, Aichi 466-8550, Japan, 5Department of Psychiatry, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawaku, Tokyo 142-8666, Japan and 6Clinical Brain Disorders Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
Received May 13, 2004; Accepted August 23, 2004
Genetic variation in dysbindin (DTNBP1: dystrobrevin-binding protein 1) has recently been shown to be associated with schizophrenia. The dysbindin gene is located at chromosome 6p22.3, one of the most promising susceptibility loci in schizophrenia linkage studies. We attempted to replicate this association in a Japanese sample of 670 patients with schizophrenia and 588 controls. We found a nominally significant association with schizophrenia for four single nucleotide polymorphisms and stronger evidence for association in a multi-marker haplotype analysis (P=0.00028). We then explored functions of dysbindin protein in primary cortical neuronal culture. Overexpression of dysbindin induced the expression of two pre-synaptic proteins, SNAP25 and synapsin I, and increased extracellular basal glutamate levels and release of glutamate evoked by high potassium. Conversely, knockdown of endogenous dysbindin protein by small interfering RNA (siRNA) resulted in the reduction of pre-synaptic protein expression and glutamate release, suggesting that dysbindin might influence exocytotic glutamate release via upregulation of the molecules in pre-synaptic machinery. The overexpression of dysbindin increased phosphorylation of Akt protein and protected cortical neurons against neuronal death due to serum deprivation and these effects were blocked by LY294002, a phosphatidylinositol 3-kinase (PI3-kinase) inhibitor. SiRNA-mediated silencing of dysbindin protein diminished Akt phosphorylation and facilitated neuronal death induced by serum deprivation, suggesting that dysbindin promotes neuronal viability through PI3-kinase-Akt signaling. Genetic variants associated with impairments of these functions of dysbindin could play an important role in the pathogenesis of schizophrenia.
* To whom correspondence should be addressed. Tel: +81 423412711; Fax: +81 423461744; Email: rhashimo{at}ncnp.go.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. K. Dickman and G. W. Davis The Schizophrenia Susceptibility Gene dysbindin Controls Synaptic Homeostasis Science, November 20, 2009; 326(5956): 1127 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, F. Yang, F. Papaleo, H.-X. Wang, W.-J. Gao, D. R. Weinberger, and B. Lu Role of dysbindin in dopamine receptor trafficking and cortical GABA function PNAS, November 17, 2009; 106(46): 19593 - 19598. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-W. Chen, Y.-Q. Feng, C.-J. Hao, X.-L. Guo, X. He, Z.-Y. Zhou, N. Guo, H.-P. Huang, W. Xiong, H. Zheng, et al. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release J. Cell Biol., October 20, 2008; 181(5): 791 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ivleva, G. Thaker, and C. A. Tamminga Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder Schizophr Bull, July 1, 2008; 34(4): 734 - 742. [Full Text] [PDF] |
||||
![]() |
N. J. Bray Gene Expression in the Etiology of Schizophrenia Schizophr Bull, May 1, 2008; 34(3): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Iizuka, Y. Sei, D. R. Weinberger, and R. E. Straub Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D2 Receptor Internalization and Signaling But Not D1 Internalization J. Neurosci., November 7, 2007; 27(45): 12390 - 12395. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McClellan, E. Susser, and M.-C. King Schizophrenia: a common disease caused by multiple rare alleles The British Journal of Psychiatry, March 1, 2007; 190(3): 194 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. G. Setty, D. Tenza, S. T. Truschel, E. Chou, E. V. Sviderskaya, A. C. Theos, M. L. Lamoreux, S. M. Di Pietro, M. Starcevic, D. C. Bennett, et al. BLOC-1 Is Required for Cargo-specific Sorting from Vacuolar Early Endosomes toward Lysosome-related Organelles Mol. Biol. Cell, March 1, 2007; 18(3): 768 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Newell-Litwa, E. Seong, M. Burmeister, and V. Faundez Neuronal and non-neuronal functions of the AP-3 sorting machinery J. Cell Sci., February 15, 2007; 120(4): 531 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hashimoto, T. Numakawa, T. Ohnishi, E. Kumamaru, Y. Yagasaki, T. Ishimoto, T. Mori, K. Nemoto, N. Adachi, A. Izumi, et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling Hum. Mol. Genet., October 15, 2006; 15(20): 3024 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Talbot, D.-S. Cho, W.-Y. Ong, M. A. Benson, L.-Y. Han, H. A. Kazi, J. Kamins, C.-G. Hahn, D. J. Blake, and S. E. Arnold Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin Hum. Mol. Genet., October 15, 2006; 15(20): 3041 - 3054. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Salazar, B. Craige, M. L. Styers, K. A. Newell-Litwa, M. M. Doucette, B. H. Wainer, J. M. Falcon-Perez, E. C. Dell'Angelica, A. A. Peden, E. Werner, et al. BLOC-1 Complex Deficiency Alters the Targeting of Adaptor Protein Complex-3 Cargoes Mol. Biol. Cell, September 1, 2006; 17(9): 4014 - 4026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gogos and D. J. Gerber Schizophrenia Susceptibility Genes: Emergence of Positional Candidates and Future Directions Focus, August 1, 2006; 4(3): 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Burdick, T. Lencz, B. Funke, C. T. Finn, P. R. Szeszko, J. M. Kane, R. Kucherlapati, and A. K. Malhotra Genetic variation in DTNBP1 influences general cognitive ability Hum. Mol. Genet., May 15, 2006; 15(10): 1563 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yagasaki, T. Numakawa, E. Kumamaru, T. Hayashi, T.-P. Su, and H. Kunugi Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release J. Biol. Chem., May 5, 2006; 281(18): 12941 - 12949. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. L. Gough and M. C. O'Donovan Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J Psychopharmacol, November 1, 2005; 19(6_suppl): 47 - 55. [Abstract] [PDF] |
||||
![]() |
K. S. KENDLER Dr. Kendler Replies Am J Psychiatry, October 1, 2005; 162(10): 1985 - 1986. [Full Text] [PDF] |
||||
![]() |
N. M Williams, M. C O'Donovan, and M. J Owen Is the Dysbindin Gene (DTNBP1) a Susceptibility Gene for Schizophrenia? Schizophr Bull, October 1, 2005; 31(4): 800 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Bray, A. Preece, N. M. Williams, V. Moskvina, P. R. Buckland, M. J. Owen, and M. C. O'Donovan Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression Hum. Mol. Genet., July 15, 2005; 14(14): 1947 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Craddock, M C O'Donovan, and M J Owen The genetics of schizophrenia and bipolar disorder: dissecting psychosis J. Med. Genet., March 1, 2005; 42(3): 193 - 204. [Abstract] [Full Text] [PDF] |
||||













